Bausch (BHC) Loses 39% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 07/29/22
Bausch Health stock tumbles toward lowest close since 1995 after confirming disappointing court rulingMarket Watch • 07/29/22
Bausch Health Halted After Patent Ruling. Why It Could Be the 'Worst Possible Outcome.Barrons • 07/28/22
Bausch Health Provides Update Following Oral Order in XIFAXAN® Patent LitigationPRNewsWire • 07/28/22
Bausch Health stock plummets toward 27-year low after Bloomberg report of unfavorable court rulingMarket Watch • 07/28/22
Bausch Health Companies Inc. Will Release Second-Quarter 2022 Financial Results on Aug. 9PRNewsWire • 07/27/22
Bausch Health Announces 2022 Annual Meeting of Shareholder Results, Updates to its Board of DirectorsPRNewsWire • 06/23/22
Bausch Health Issues Form 8-K for 2022 Annual Meeting of Shareholders PresentationPRNewsWire • 06/21/22
Salix to Share New Data from XIFAXAN® (Rifaximin) Clinical Research at EASL's International Liver Congress™ 2022PRNewsWire • 06/20/22